| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Stramonium |
Is a |
True |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Hyoscyamine (substance) |
Is a |
True |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Belladonna (substance) |
Is a |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| aluminiumhydroxid + belladonna som mikstur |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| belladonna 0,05 mg/5 ml pædiatrisk væske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| magnesiumtrisilicat + belladonna 0,15 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Product containing precisely belladonna alkaloid 200 microgram and ergotamine tartrate 600 microgram and phenobarbital 40 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| belladonna-alkaloider 0,2 mg + ergotamintartrat 0,6 mg + phenobarbital 40 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Product containing naturally occurring alkaloid (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
1 |
| belladonna-præparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Belladonna alkaloid 15 mg and secbutabarbital sodium 15 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| aluminiumhydroxid + belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| belladonna + butabarbitalnatrium |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| belladonna-alkaloider + ergotamintartrat + phenobarbital |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| magnesiumtrisilikat + belladonna |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Plant alkaloid |
Is a |
True |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Hyoscyamine sulfate |
Is a |
True |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Hyoscyamine sulfate dihydrate (substance) |
Is a |
True |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Hyoscyamine hydrobromide (substance) |
Is a |
True |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
| Hyoscyamine sulfate anhydrous (substance) |
Is a |
True |
Naturally occurring alkaloid (substance) |
Inferred relationship |
Some |
|
FHIR